Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Conclusion
Among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Guan, W.-j., Liang, W.-h., Zhao, Y., Liang, H.-r., Chen, Z.-s., Li, Y.-m., Liu, X.-q., Chen, R.-c., Tang, C.-l., Wang, T., Ou, C.-q., Li, L., Chen, P.-y., Sang, L., Wang, W., Li, J.-f., Li, C.-c., Ou, L.-m., Cheng, B., Xiong, S., Ni, Z.-y., Xiang, J., Hu, Tags: Respiratory infections and tuberculosis Original Articles: Infectious disease Source Type: research
More News: Cancer & Oncology | China Health | Chronic Obstructive Pulmonary | Coronavirus | COVID-19 | Diabetes | Endocrinology | Hypertension | Infectious Diseases | Intensive Care | Laboratory Medicine | Outbreaks | Respiratory Medicine | Smokers | Study | Tuberculosis